Brief: Arix Bioscience Updates On Imara Proposed IPO In The U.S.
March 3 (Reuters) - Arix Bioscience PLC ARIX.L :
* REG-ARIX BIOSCIENCE PLC: UPDATE ON IMARA PROPOSED IPO IN
THE
UNITED STATES
* NOTES THAT IMARA FILED AMENDED REGISTRATION STATEMENT ON
FORM
S-1 WITH SEC ON PROPOSED IPO IN UNITED STATES
* ARIX HAS INDICATED INTEREST IN PURCHASING COMMON SHARES IN
PROPOSED IPO OF IMARA
Source text for Eikon: ID:nPRr33311a
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com ;;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co